Doxofylline is a methylxanthine derivative used as a bronchodilator in the treatment of asthma and chronic obstructive pulmonary disease (COPD). It is grouped under the following drug class(es): Bronchodilators and Methylxanthines. Its therapeutic use is listed as anti-asthmatic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Ansimar, Ventax and Synasma. Its PubChem CID is 50942.
Doxofylline
| CAS No | 69975-86-6 |
|---|---|
| Molecular Formula | C11H14N4O4 |
| Molecular Weight | 266.25 g/mol |
| Synonyms | 7-(1,3-dioxolan-2-ylmethyl)-1,3-dimethylpurine-2,6-dione |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Doxofylline is a methylxanthine derivative used as a bronchodilator in the treatment of asthma and chronic obstructive pulmonary disease (COPD). It is grouped under the following drug class(es): Bronchodilators and Methylxanthines.
The listed CAS number is 69975-86-6.
The listed molecular formula is C11H14N4O4.
The listed molecular weight is 266.25 g/mol.
7-(1,3-dioxolan-2-ylmethyl)-1,3-dimethylpurine-2,6-dione.
The source lists Ansimar, Ventax and Synasma.